Healthcare

‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause

By Zach Halaschak
Published October 13, 2020 1:50am ET
Add Washington Examiner on Google
‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause
A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys. | (Sakchai Lalit/AP)

A coronavirus vaccine study by Johnson & Johnson has been put on pause after one of the study’s participants had an “unexpected illness.”

An independent safety monitoring board will review the patient’s case as will internal clinical and safety physicians, the company said in a Monday evening news release.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 Pharmaceutical Industry Science Vaccines